Back to all available

IL20RB promotes proliferation and migration in Clear Cell Renal Cell Carcinoma and is associated with immune infiltration

biochemistry
bioinformatics
cell-biology
oncology

Abstract

Background: IL20RB, interleukin 20 receptor subunit beta, functions as a cytokine receptor subunit coding gene and has been discovered to serve an essential function in human malignancies. However, the link between IL20RB expression, clinical outcomes, and tumor-infiltrating lymphocytes in ccRCC (clear cell renal cell carcinoma) remains unclear.

Methods: The Cancer Genome Atlas (TCGA) was utilized to compile data on the IL20RB expression in both normal and ccRCC tissues. The link between IL20RB expression and clinicopathologic characteristics was examined utilizing the TCGA database. Kaplan-Meier survival curves were employed for performing the survival analysis. Furthermore, a protein network involving IL20RB was established using data from the GeneMANIA database. Gene Ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) were undertaken, and the relationship between IL20RB and tumor immune infiltration was examined via single-sample GSEA (ssGSEA). Additional examination of the link between tumor-infiltrating immune cells (TIIC) and IL20RB was executed utilizing the TIMER and TISIDB databases. IL20RB expression in tumor specimens was detected through immunohistochemistry (IHC). IL20RB expression levels in tumor cells were confirmed via Western blot analysis. Cell counting kit-8 (CCK-8) and colony formation assays evaluated IL20RB’s impact on ccRCC cell viability. Wound Healing and Transwell assays assessed IL20RB’s influence on ccRCC cell migration.

Results: Peritumor samples exhibited notably reduced IL20RB expression compared to ccRCC samples. IL20RB expression levels correlated markedly with sample classification, lymph node status, tumor differentiation, and disease progression. Enhanced IL20RB expression is linked to poor Disease-Specific Survival (DSS) and Overall Survival (OS) in ccRCC patients (p<0.01). Subsequently, a significant link was observed between IL20RB overexpression and immunomodulators, chemokines, and a heightened presence of infiltrating Treg, NK CD56 cells, Th1 cells, cytotoxic cells, and T helper cells in ccRCC. IHC showed that the IL20RB level in the adjacent normal tissues was notably diminished relative to that in ccRCC samples. IL20RB suppression through small interfering RNA (siRNA) markedly diminished ccRCC cell proliferation and migration.

Conclusion: Heightened IL20RB expression is linked to a dismal prognosis and infiltration of immune cells in ccRCC, indicating its potential importance in the development of immunotherapeutic strategies.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.
  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].